Diabetes

COVID-19 infection has been associated with a rapid progression to clinical type 1 diabetes in young individuals with presymptomatic disease, according to a recent study.

New research suggests semaglutide, a medication for type 2 diabetes and obesity, may help reduce tobacco use disorder risks.

Novel findings showed a link between irregular sleep duration and the risk of developing diabetes, highlighting the potential metabolic consequences of sleep variability.

New findings have shown a link between gestational diabetes mellitus in mothers and the increased risk of their children being overweight, mediated by higher fetal growth rates.

A recent study suggests that 5:2 intermittent fasting meal replacement diet could be an effective initial lifestyle intervention for managing early type 2 diabetes.

New research indicates a potential link between semaglutide, a GLP-1 receptor agonist, and a higher risk of NAION in type 2 diabetes and overweight patients.

New findings highlighted a concerning trend in the discontinuation rates of Glucagon-like peptide-1 receptor agonists among patients with type 2 diabetes and obesity.

According to recent findings, social determinants of health significantly influence diabetic retinopathy care.